Iron metabolism and type 2 diabetes mellitus: A meta‐analysis and systematic review

Jingfang Liu,Qingxiu Li,Yaxian Yang,Lihua Ma
DOI: https://doi.org/10.1111/jdi.13216
2020-02-23
Journal of Diabetes Investigation
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aim</h3><p>Iron metabolism can directly or indirectly affect the occurrence and development of type 2 diabetes. This meta‐analysis and systematic review aimed to analyze the association between serum iron metabolism indicators and type 2 diabetes.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>The databases PubMed and Embase were searched for studies on the correlations between serum iron metabolism indicators (iron, ferritin, transferrin, hepcidin, and soluble transferrin receptor) and type 2 diabetes since January 2006. Relevant data were extracted from the included studies, and meta‐analysis was performed.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>12 case‐control and cohort studies were analyzed11/12 studies described the correlation between serum ferritin levels and type 2 diabetes. The median and high serum ferritin concentrations were significantly associated with the risks of type 2 diabetes [OR1.20, 95% CI (1.08, 1.33)] and [OR1.43, 95% CI (1.29, 1.59)], respectively. However, the low concentration was not correlated with the risk of type 2 diabetes [OR 0.99, 95% CI (0.89, 1.11)]. No significant association was observed between serum soluble transferrin receptor and type 2 diabetes, while the soluble transferrin receptor‐to‐ferritin ratio was significantly inversely related to the risk of type 2 diabetes in the median and high ratio subgroups [OR 0.71, 95% CI (0.51, 0.99)] and [OR 0.65, 95% CI (0.45, 0.95)]. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>The elevated serum ferritin was one of the risk factors for type 2 diabetes, and soluble transferrin receptor to ferritin ratio was inversely related to the risk of type 2 diabetes. A systematic review showed that serum transferrin and hepcidin might be directly or indirectly related to the development of diabetes.</p></section>
endocrinology & metabolism
What problem does this paper attempt to address?